NDC 0003-3622

REYATAZ

Atazanavir

REYATAZ is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Atazanavir Sulfate.

• Product ID: 0003-3622_1cab2232-648a-4961-a179-30087315de3b
• NDC: 0003-3622
• Product Type: Human Prescription Drug
• Proprietary Name: REYATAZ
• Generic Name: Atazanavir
• Dosage Form: Capsule, Gelatin Coated
• Route of Administration: ORAL
• Marketing Start Date: 2003-06-24
• Marketing Category: NDA / NDA
• Application Number: NDA021567
• Labeler Name: E.R. Squibb & Sons, L.L.C.
• Substance Name: ATAZANAVIR SULFATE
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0003-3622-12

30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3622-12)

• Marketing Start Date: 2003-06-24
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0003-3622-12 [00003362212]

REYATAZ CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA021567
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-06-24

Drug Details

Active Ingredients

Ingredient	Strength
ATAZANAVIR SULFATE	300 mg/1

OpenFDA Data

• SPL SET ID: 165cff62-b284-4a27-a65d-9ec8a5bfcdd8
• Manufacturer:
  • E.R. Squibb & Sons, L.L.C.
• UNII:
  • 4MT4VIE29P
• RxNorm Concept Unique ID - RxCUI:
  • 402246
  • 1598985
  • 1598989
  • 402093
  • 664741
  • 402247
  • 664743
  • 402094
• UPC Code:
  • 0044000000042
  • 0300000000001

Pharmacological Class

• HIV Protease Inhibitors [MoA]
• Protease Inhibitor [EPC]
• UGT1A1 Inhibitors [MoA]
• UDP Glucuronosyltransferases Inhibitors [MoA]
• Cytochrome P450 3A4 Inhibitors [MoA]
• Cytochrome P450 3A Inhibitors [MoA]
• Cytochrome P450 2C8 Inhibitors [MoA]
• HIV Protease Inhibitors [MoA]
• Protease Inhibitor [EPC]
• UGT1A1 Inhibitors [MoA]
• UDP Glucuronosyltransferases Inhibitors [MoA]
• Cytochrome P450 3A4 Inhibitors [MoA]
• Cytochrome P450 3A Inhibitors [MoA]
• Cytochrome P450 2C8 Inhibitors [MoA]

NDC Crossover Matching brand name "REYATAZ" or generic name "Atazanavir"

NDC	Brand Name	Generic Name
0003-3622	REYATAZ	ATAZANAVIR
0003-3624	REYATAZ	ATAZANAVIR
0003-3631	REYATAZ	ATAZANAVIR
0003-3638	REYATAZ	ATAZANAVIR
50090-1007	REYATAZ	ATAZANAVIR
50090-1581	REYATAZ	ATAZANAVIR
69189-3631	REYATAZ	REYATAZ
69189-3624	REYATAZ	REYATAZ
70518-0725	REYATAZ	REYATAZ
70518-0688	REYATAZ	REYATAZ
70518-0469	REYATAZ	REYATAZ
67296-1236	REYATAZ	REYATAZ
31722-653	Atazanavir	Atazanavir
31722-654	Atazanavir	Atazanavir
31722-655	Atazanavir	Atazanavir
42385-920	Atazanavir	Atazanavir
42385-921	Atazanavir	Atazanavir
42385-922	Atazanavir	Atazanavir
59762-0408	ATAZANAVIR	ATAZANAVIR
59762-0409	ATAZANAVIR	ATAZANAVIR
59762-0410	ATAZANAVIR	ATAZANAVIR
0904-6875	Atazanavir Sulfate	Atazanavir
16714-860	Atazanavir Sulfate	Atazanavir
16714-861	Atazanavir Sulfate	Atazanavir
16714-862	Atazanavir Sulfate	Atazanavir
60687-399	Atazanavir Sulfate	Atazanavir
65862-710	Atazanavir Sulfate	Atazanavir
65862-711	Atazanavir Sulfate	Atazanavir